Directed iPSC Differentiation
iPSC Differentiation Services
Generate lineage-specific progenitors and differentiated cell types from client-provided or iPSCU-generated iPSC lines for disease modeling, screening, functional studies, assay development, and translational research.
Final scope, starting-line requirements, maturity target, QC, timeline, and deliverables are confirmed in a formal quote before work begins.
From Pluripotency to Your Target Lineage
Custom Differentiation Built Around the Cell Type You Need
iPSCU provides directed differentiation services for academic, biotechnology, and pharmaceutical research programs requiring defined human cell types generated from induced pluripotent stem cells.
Projects can begin with a qualified client-provided iPSC line or with an iPSC line generated through our reprogramming service. Gene-edited or disease-relevant iPSC lines can also be incorporated into differentiation programs when appropriate.
Because differentiation requirements vary by lineage, projects are scoped around the target cell type, desired developmental stage or maturity, required quantity, characterization strategy, downstream application, and delivery format.
Available Cell Types
Directed Differentiation Across Major Human Cell Lineages
Our current service portfolio includes 24 target cell types and co-culture options. If your target is not listed, contact us to discuss feasibility.
Neural & Glial Cells
- Neural Progenitor Cells (NPCs)
- Motor Neurons
- Cortical Neurons
- GABAergic Neurons
- Enteric Neurons
- Dopaminergic Neurons
- Sensory Neurons
- Microglia
- Astrocytes
- Oligodendrocytes
- Neuron / Astrocyte Co-Culture
Blood, Immune & Hematopoietic
- Hematopoietic Progenitor Cells (HPCs)
- Monocytes
- Macrophages
- Natural Killer (NK) Cells
- T Cells
Cardiac & Muscle
- Cardiomyocytes
- Skeletal Muscle Cells
Metabolic & Endodermal
- Beta Cells
- Hepatocytes
Mesenchymal & Skeletal
- Mesenchymal Stromal / Stem Cells (MSCs)
- Chondrocytes
Retinal Cells
- Photoreceptors
- Retinal Pigment Epithelium (RPE)
How It Works
A Differentiation Workflow Defined by Your Target Cell Type
The exact protocol and timeline vary by lineage, but the project path is straightforward and milestone-driven.
Project Definition
Confirm target lineage, starting iPSC line, maturity, quantity, QC, application, and delivery needs.
iPSC Recovery & Expansion
Recover and expand the starting iPSC culture to establish suitable material for differentiation.
Directed Differentiation
Move iPSCs through lineage-appropriate precursor stages toward the requested cell type.
Characterization
Evaluate lineage identity using appropriate markers and add functional assays when included in scope.
Delivery
Prepare the agreed cell format, QC results, images, and project documentation.
Quality Control & Characterization
QC Matched to the Biology of the Target Cell
A single QC panel does not fit every differentiated lineage. Characterization is selected around target phenotype, maturity, downstream use, and project requirements.
Identity & Lineage Markers
Lineage-marker staining is included as standard QC. The specific marker panel is selected for the requested progenitor or differentiated phenotype and defined for each project.
Imaging & Morphology
Marker-staining images are included as standard QC, with morphology and other imaging added as appropriate to the lineage and project scope.
Functional Characterization
Where appropriate, functional readouts can support the intended research application or confirm lineage-specific activity.
Project Deliverables
Deliverables Defined Around How You Plan to Use the Cells
Differentiated Cells
Target-lineage progenitors or differentiated cells generated from the agreed iPSC line.
Cell Format
Cryopreserved cells are the standard delivery format, with other project-appropriate formats discussed when needed for the lineage or downstream workflow.
QC & Images
Standard lineage-marker staining images plus the QC results and any additional characterization defined in the formal scope.
Project Documentation
Milestone and/or final reporting appropriate to the agreed service package.
Research Applications
Build More Relevant Human Cellular Models
Disease Modeling
Generate disease-relevant or patient-derived lineages for mechanistic and phenotype studies.
Drug Discovery & Screening
Use differentiated human cells in target validation, screening, and compound-response workflows.
Functional Studies
Investigate lineage-specific biology, pathways, cellular function, and treatment response.
Assay Development
Create fit-for-purpose cellular systems for translational and preclinical workflows.
Integrated iPSC Workflows
Combine Differentiation with Reprogramming or Gene Editing
We can structure a broader workflow when your project begins with a patient sample or requires an engineered iPSC model before lineage differentiation.
Planning Your Project
What We Need to Prepare a Differentiation Quote
Lineage, maturity, scale, and characterization can materially change a differentiation program, so a few details help us define the correct scope quickly.
- Target cell type or lineage
- Starting iPSC line and source
- Healthy, patient-derived, or gene-edited status
- Desired precursor or maturity stage
- Required cell quantity and delivery format
- Required identity, purity, or functional QC
- Number of lines or clones
- Downstream assay or application
- Target project timeline
Frequently Asked Questions
iPSC Differentiation Service FAQs
Common questions about starting lines, available cell types, characterization, timelines, and integrated workflows.
What cell types can iPSCU generate from iPSCs?
Our current portfolio includes neural progenitor cells, multiple neuronal subtypes, microglia, astrocytes, oligodendrocytes, hematopoietic progenitor cells, monocytes, macrophages, NK cells, T cells, cardiomyocytes, skeletal muscle cells, beta cells, hepatocytes, MSCs, chondrocytes, photoreceptors, RPE, and neuron/astrocyte co-cultures.
Can you start with my existing iPSC line?
Yes. Projects can begin with a qualified client-provided iPSC line. We review the starting line and project requirements before finalizing scope.
Can you generate the iPSC line first and then differentiate it?
Yes. A project can be structured as reprogramming followed by differentiation of selected iPSC clones.
Can gene-edited iPSCs be differentiated?
Yes. Gene editing can be performed before differentiation when the study requires an engineered, reporter, knockout, knock-in, or disease-model iPSC line.
Do you provide progenitor cells or fully differentiated cells?
Both may be possible depending on lineage and project goals. The developmental stage, maturity target, and delivery point are defined during project scoping.
What QC is performed?
Lineage-marker staining and images are standard QC. The specific marker panel is project-specific, and additional morphology or functional assays can be included when appropriate to the target cell and downstream application.
How long does differentiation take?
Turnaround is generally efficient, but the actual timeline depends on lineage, maturity, starting line, scale, and characterization requirements. The expected timeline is provided in the formal quote.
Can you generate neuron/astrocyte co-cultures?
Yes. Neuron/astrocyte co-culture is included among our current offerings; subtype, ratio, maturity, format, and QC can be scoped to the application.
What if my target cell type is not listed?
Contact us with the desired lineage and application. We can review feasibility for a custom differentiation workflow.
Ready to Start?
Discuss Your iPSC Differentiation Project
Tell us the target cell type, starting iPSC line, desired maturity, scale, QC requirements, and downstream application. We can review the project and prepare a formal quote.